Ikena Oncology, Inc.
NASDAQ:IKNA
1.71 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.659 | 1.185 | 2.004 | 5.313 | 5.45 | 6.402 | 0.382 | 3.384 | 20.217 | 3.746 | 3.549 | 3.474 | 0.065 | 2.829 | 3.073 | 3.227 | 2.804 |
| Cost of Revenue
| 0.092 | 0.219 | 0.305 | 0.242 | 0.586 | 0.568 | 0.381 | 18.85 | 15.488 | 14.343 | 12.338 | 13.375 | 11.374 | 10.021 | 23.402 | 7.218 | 6.334 | 7.893 | 5.964 |
| Gross Profit
| -0.092 | -0.219 | 0.354 | 0.943 | 1.418 | 4.745 | 5.069 | -12.448 | -15.106 | -10.959 | 7.879 | -9.629 | -7.825 | -6.547 | -23.337 | -4.389 | -3.261 | -4.666 | -3.16 |
| Gross Profit Ratio
| 0 | 0 | 0.537 | 0.796 | 0.708 | 0.893 | 0.93 | -1.944 | -39.545 | -3.238 | 0.39 | -2.57 | -2.205 | -1.885 | -359.031 | -1.551 | -1.061 | -1.446 | -1.127 |
| Reseach & Development Expenses
| 9.74 | 9.426 | 13.969 | 1.185 | 15.172 | 15.552 | 15.639 | 18.85 | 15.488 | 14.343 | 12.338 | 13.375 | 11.374 | 10.021 | 23.402 | 7.218 | 6.334 | 7.893 | 5.964 |
| General & Administrative Expenses
| 5.308 | 5.999 | 8.293 | 6.034 | 5.322 | 5.276 | 4.925 | 5.428 | 5.845 | 6.003 | 5.087 | 4.893 | 4.862 | 3.173 | 2.716 | 1.844 | 1.798 | 2.51 | 2.283 |
| Selling & Marketing Expenses
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.308 | 5.999 | 8.293 | 6.034 | 5.322 | 5.276 | 4.925 | 5.428 | 5.845 | 6.003 | 5.087 | 4.893 | 4.862 | 3.173 | 2.716 | 1.844 | 1.798 | 2.51 | 2.283 |
| Other Expenses
| 0.235 | -0.007 | -0.014 | 13.469 | -0.006 | 0.566 | 0.124 | -0.038 | -0.047 | -0.049 | 0.005 | 0.007 | 0.006 | 0.004 | 0.002 | 0.011 | 0.021 | 0.231 | 0 |
| Operating Expenses
| 15.048 | 15.425 | 22.262 | 20.688 | 20.494 | 20.828 | 20.564 | 24.278 | 21.333 | 20.346 | 17.425 | 18.268 | 16.236 | 13.194 | 26.118 | 9.062 | 8.132 | 10.403 | 1.948 |
| Operating Income
| -15.14 | -15.644 | -21.908 | -19.503 | -18.49 | -15.515 | -15.114 | -17.876 | -20.951 | -16.962 | 2.792 | -14.522 | -12.687 | -9.72 | -26.053 | -6.233 | -5.059 | -7.176 | -5.443 |
| Operating Income Ratio
| 0 | 0 | -33.244 | -16.458 | -9.227 | -2.92 | -2.773 | -2.792 | -54.846 | -5.012 | 0.138 | -3.877 | -3.575 | -2.798 | -400.815 | -2.203 | -1.646 | -2.224 | -1.941 |
| Total Other Income Expenses Net
| 1.472 | -0.475 | 2.257 | 2.16 | 1.375 | 1.296 | 1.017 | 0.538 | 0.46 | 0.123 | 0.005 | 0.007 | 0.006 | 0.004 | 0.002 | 0.011 | 0.021 | 0.231 | 0.335 |
| Income Before Tax
| -13.668 | -16.119 | -19.651 | -17.343 | -17.115 | -14.219 | -14.097 | -17.338 | -20.491 | -16.839 | 2.797 | -14.515 | -12.681 | -9.716 | -26.051 | -6.222 | -5.038 | -6.945 | -5.108 |
| Income Before Tax Ratio
| 0 | 0 | -29.819 | -14.635 | -8.54 | -2.676 | -2.587 | -2.708 | -53.641 | -4.976 | 0.138 | -3.875 | -3.573 | -2.797 | -400.785 | -2.199 | -1.639 | -2.152 | -1.822 |
| Income Tax Expense
| 0.062 | 0.027 | -0.162 | -0.242 | -1.381 | -1.296 | -1.017 | -0.538 | -0.46 | -0.123 | -0.306 | 0.421 | 0.273 | -0.273 | 0 | 0.392 | 0 | 0 | 0 |
| Net Income
| -13.73 | -16.146 | -19.489 | -17.343 | -17.115 | -12.923 | -13.08 | -16.8 | -20.031 | -16.716 | 2.797 | -14.515 | -12.681 | -9.716 | -26.051 | -6.222 | -5.038 | -6.945 | -5.108 |
| Net Income Ratio
| 0 | 0 | -29.574 | -14.635 | -8.54 | -2.432 | -2.4 | -2.624 | -52.437 | -4.94 | 0.138 | -3.875 | -3.573 | -2.797 | -400.785 | -2.199 | -1.639 | -2.152 | -1.822 |
| EPS
| -0.28 | -0.33 | -0.41 | -0.4 | -0.44 | -0.36 | -0.36 | -0.46 | -0.55 | -0.46 | 0.078 | -0.4 | -0.35 | -2.52 | -1.86 | -0.44 | -0.36 | -0.5 | -1.93 |
| EPS Diluted
| -0.28 | -0.33 | -0.41 | -0.4 | -0.44 | -0.36 | -0.36 | -0.46 | -0.55 | -0.46 | 0.078 | -0.4 | -0.35 | -2.52 | -1.86 | -0.44 | -0.36 | -0.5 | -1.93 |
| EBITDA
| -15.048 | -15.425 | -21.603 | -19.503 | -19.629 | -15.284 | -14.904 | -17.663 | -20.803 | -16.782 | 2.955 | -14.522 | -11.974 | -9.631 | -25.978 | -6.233 | -4.516 | -7.102 | -5.378 |
| EBITDA Ratio
| 0 | 0 | -32.781 | -16.458 | -9.795 | -2.877 | -2.735 | -2.759 | -54.458 | -4.959 | 0.146 | -3.877 | -3.374 | -2.772 | -399.662 | -2.203 | -1.47 | -2.201 | -1.918 |